SelectQuote Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
4analysts covering
FY Revenue (est.)
$1.7Bnext fiscal year
FY EPS (est.)
$0.07next fiscal year
Monitoring Framework
Key Performance Indicators
Approved Medicare Advantage Policies Quarterly175.6K
SelectRx Pharmacy Membership Quarterly116.6K
Revenue-to-Customer-Acquisition-Cost (CAC) Multiple Quarterly6.7
Watch Items
- Medicare Advantage Regulatory Scrutiny and Enrollment EfficiencyTrigger: Changes in CMS reimbursement rates or enrollment guidelinesAction: Optimize agent routing technology and focus marketing spend on high Lifetime Value (LTV) customers.
- SelectRx Pharmacy Reimbursement PressuresTrigger: EBITDA margin compression in Healthcare Services segmentAction: Collaborate with PBM partners to stabilize reimbursement rates and scale membership to drive operational leverage.
Research as of 20 Jun 2026